Is Copegus the Same as Ribavirin?
Yes, Copegus is ribavirin. Copegus is the brand name for ribavirin capsules manufactured by Roche, used to treat chronic hepatitis C virus (HCV) infection in combination with interferon.[1]
How Does Copegus Differ from Generic Ribavirin?
Copegus is a specific branded formulation of ribavirin (400 mg capsules), while generic ribavirin is available from multiple manufacturers in various strengths like 200 mg or 400 mg tablets or capsules. They have the same active ingredient and identical mechanism—interfering with viral RNA synthesis—but generics may differ in inactive ingredients, which can affect tolerability for some patients.[1][2]
Common Uses for Copegus and Ribavirin
Both treat HCV genotypes 1-6 alongside peginterferon alfa, with approval for adults and children over 3 years. Ribavirin boosts response rates but is less common today due to direct-acting antivirals like sofosbuvir. It's also used off-label for respiratory syncytial virus (RSV) in high-risk infants.[2]
What Side Effects Do Patients Report?
Hemolytic anemia (dose-limiting in 10-20% of users), fatigue, insomnia, and birth defects if used during pregnancy (requires contraception for 6 months post-treatment). Monitoring hemoglobin is standard.[2]
When Did Copegus Patents Expire?
Copegus U.S. patents expired around 2015-2016, allowing generics to enter. No active patents block competition today.[3] Check DrugPatentWatch.com for latest status.
Alternatives to Copegus/Ribavirin Today
Modern HCV treatments like Epclusa (sofosbuvir/velpatasvir) or Mavyret (glecaprevir/pibrentasvir) are interferon- and ribavirin-free, with cure rates over 95% in 8-12 weeks and fewer side effects.[2]
Sources:
[1] FDA Label: Copegus (ribavirin)
[2] NIH Hepatitis C Treatment Guidelines
[3] DrugPatentWatch.com